Ftse Mib
38.423,16
1,11%
DAX
22.896,01
1,61%
S&P 500
5.521,52
-1,39%
NASDAQ
0,00
0,00%
Bitcoin
83.273,55
2,76%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ bluebird bio Inc (BLUE) bluebird bio Inc (BLUE) Notizie

BLUE

bluebird bio (BLUE)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BLUE
DataOraFonteTitoloSimboloCompagnia
07/03/202515:32Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:BLUEbluebird bio Inc
07/03/202515:25Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:BLUEbluebird bio Inc
05/03/202522:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BLUEbluebird bio Inc
03/03/202523:51Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLUEbluebird bio Inc
21/02/202523:22Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:BLUEbluebird bio Inc
21/02/202522:48Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:BLUEbluebird bio Inc
21/02/202521:43PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of bluebird bio, Inc.NASDAQ:BLUEbluebird bio Inc
21/02/202514:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLUEbluebird bio Inc
21/02/202513:30Business Wirebluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK CapitalNASDAQ:BLUEbluebird bio Inc
08/12/202418:30Business Wirebluebird bio Presents Positive Long-Term Data On LYFGENIA™ (lovotobegligene autotemcel) Gene Therapy for Sickle Cell Disease at 66th American Society of Hematology (ASH) Annual Meeting and ExpositionNASDAQ:BLUEbluebird bio Inc
07/12/202418:00Business WireLong-Term Follow-Up Data Continue to Support Beti-Cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independence and Normal or Near-Normal Adult Hb LevelsNASDAQ:BLUEbluebird bio Inc
04/12/202422:05Business Wirebluebird bio Announces 1-for-20 Reverse Stock SplitNASDAQ:BLUEbluebird bio Inc
04/12/202414:47Business Wirebluebird bio Confirms Participation in Center for Medicare and Medicaid Innovation (CMMI) Cell and Gene Therapy Access ModelNASDAQ:BLUEbluebird bio Inc
14/11/202422:39Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BLUEbluebird bio Inc
14/11/202422:38Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BLUEbluebird bio Inc
14/11/202413:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BLUEbluebird bio Inc
14/11/202413:00Business Wirebluebird bio Reports Third Quarter 2024 Results and Highlights Operational Progress and 2024 GuidanceNASDAQ:BLUEbluebird bio Inc
06/11/202422:15Business Wirebluebird bio Adjourns Meeting of Stockholders and Announces Third Quarter Results CallNASDAQ:BLUEbluebird bio Inc
05/11/202415:05Business Wirebluebird bio to Present Additional Long-Term Follow-up Data from Gene Therapy Programs in Sickle Cell Disease and Beta-Thalassemia at the 66th American Society of Hematology (ASH) Annual Meeting and ExpositionNASDAQ:BLUEbluebird bio Inc
04/10/202422:05Business Wirebluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BLUEbluebird bio Inc
27/09/202422:30Business Wirebluebird bio Announces Completion of its Q2 2024 Form 10-Q FilingNASDAQ:BLUEbluebird bio Inc
26/09/202422:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BLUEbluebird bio Inc
24/09/202413:00Business Wirebluebird bio Initiates Restructuring Intended to Optimize Cost Structure and Enable Quarterly Cash Flow Break-Even in the Second Half of 2025NASDAQ:BLUEbluebird bio Inc
16/09/202422:04Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BLUEbluebird bio Inc
13/09/202422:41Business Wirebluebird bio Announces Completion of its Restatement and filing of its 2023 Form 10-K and Q1 2024 Form 10-QNASDAQ:BLUEbluebird bio Inc
13/09/202422:28Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BLUEbluebird bio Inc
28/08/202414:00Business Wirebluebird bio Announces September Investor EventsNASDAQ:BLUEbluebird bio Inc
23/08/202422:05Business Wirebluebird bio Announces Receipt of Expected Notices from NasdaqNASDAQ:BLUEbluebird bio Inc
14/08/202413:13Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:BLUEbluebird bio Inc
14/08/202413:00Business Wirebluebird bio Reports Second Quarter 2024 Results and Highlights Operational Progress and 2024 GuidanceNASDAQ:BLUEbluebird bio Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BLUE

La tua Cronologia

HITB
BRGUSDT
Bridge Oracle
NASDAQ
MYFW
First Western Finanical
BOV
BRIT3F
Brisanet Participacoes ON
NASDAQ
ABOJGXX
Bank of Montreal Capped ...
NASDAQ
ABLEVXX
Citigroup Global Markets...
NASDAQ
ABLIUXX
Bofa Finance Llc Issuer ...
NASDAQ
ABLUJXX
Bofa Finance Llc Autocal...
EU
MLAZL
AZ Leasing
EU
WLENP
Euronext CDP Environment...
NASDAQ
ABOXLXX
Bank of Montreal Issuer ...
EU
INPHI
Royal Philips Electronic...
USOTC
SCSHF
Scottish Oriental Smalle... (PK)
USOTC
SSCFF
SmartCool Systems (CE)
FTSE
NMX651020
FTSE 350 Gas Water and M...
BOV
HYPE3Q
HYPERA ON
BOV
VIUR11
Vinci Imoveis Urbanos Fu...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci